文献速递其他结缔组织病

孤立性抗SS-B(La)抗体:罕见发生且缺乏诊断价值

Isolated anti-SS-B (La) antibodies: rare occurrence and lack of diagnostic value.
PubMed 文献 · RMD Open · 2025-02-04

该回顾性研究在巴黎三家医院评估孤立性抗SS-B抗体的患病率与诊断意义,共80540次检测中1693例抗SS-B阳性,经两种技术确认且抗SS-A阴性的孤立性抗SS-B仅61例(占抗SS-B阳性的3.6%),中位随访26个月仅新增2例诊断,结论认为孤立性抗SS-B无诊断或预后价值。

要点

  • 80540次抗SS-B检测中1693例阳性,经两种技术确认的孤立性抗SS-B仅61例,占抗SS-B阳性的3.6%。
  • 61例孤立性抗SS-B中24例(39.3%)有自身免疫或自身炎症性疾病史,仅6例诊断新结缔组织病。
  • 中位随访26个月仅新增2例诊断,孤立性抗SS-B与特定疾病无关联。

核心结论

  • 经严格免疫学方法准确识别时,无抗SS-A的抗SS-B极为罕见。
  • 初始抗SS-B阳性与特定疾病无关,中位随访26个月后亦然,支持孤立性抗SS-B无诊断或预后价值。

研究设计与样本

  • 回顾性研究,在巴黎公共医疗集团(Assistance Publique-Hôpitaux de Paris)的三家医院开展。
  • 通过ELISA、可寻址激光束免疫分析(ALBIA)和免疫印迹法识别抗SS-B阳性患者。
  • 抗SS-B在两种技术中阳性且抗SS-A阴性者纳入,共61例,提取临床、生物学和免疫学数据进行描述性分析。

主要发现

  • 7.9年间共80540次抗SS-B抗体检测申请,1693例患者抗SS-B阳性。
  • 1693例中335例(19.8%)在ELISA/ALBIA中为孤立性抗SS-B,其中186例进行免疫印迹法,61例(占抗SS-B阳性的3.6%)确认抗SS-B阳性。
  • 61例中24例(39.3%)有各种自身免疫或自身炎症性疾病史,仅6例诊断新结缔组织病。
  • 中位随访26个月后仅新增2例诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Anti-SS-B antibodies are often associated with anti-SS-A in Sjögren's disease. Compared to anti-SS-A antibody positivity, the significance of the immunological profile anti-SS-B positive/anti-SS-A negative remains controversial. We aimed to evaluate the prevalence and diagnostic significance of isolated anti-SS-B antibodies. METHODS: We conducted a retrospective study across three hospitals of the Assistance Publique-Hôpitaux de Paris. Patients with anti-SS-B positivity were identified using ELISA, addressable laser beam immunoassay (ALBIA) and immunodot assays. They were retained if anti-SS-B was positive in two techniques and anti-SS-A was absent. Clinical, biological and immunological data were extracted and presented in a descriptive analysis. RESULTS: A total of 80 540 requests for anti-SS-B antibody testing were carried out over a period of 7.9 years. Anti-SS-B positivity was found in 1693 patients. Among them, 335 (19.8%) patients had isolated anti-SS-B in ELISA/ALBIA. Immunodot was performed in 186 of them and confirmed anti-SS-B positivity in 61 patients (3.6% of anti-SS-B positivity). 24 patients (39.3%) presented with a history of various autoimmune or autoinflammatory diseases and only 6 were diagnosed with a new connective tissue disease. After a median follow-up of 26 months, only two new diagnoses were made. CONCLUSION: Anti-SS-B without anti-SS-A is exceedingly rare when accurately identified by a rigorous immunological approach. The initial anti-SS-B positivity does not correlate with a specific condition, both at the time of initial identification and after a 26-month follow-up period. This supports the fact that isolated anti-SS-B has no diagnostic or prognostic value.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Cioni P, Chretien P, Goulvestre C, et al. Isolated anti-SS-B (La) antibodies: rare occurrence and lack of diagnostic value. RMD Open. 2025. PMID: 39904568. doi:10.1136/rmdopen-2024-005212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。